Sunday, December 8, 2019

At The ASH 2019 Annual Meeting: AXLA, CBMG, SRRA, EPZM, STOK...

The following are some of the companies that presented new/updated trial data of their investigational drug candidates at the 61st Annual Meeting of the American Society of Hematology (ASH) on Saturday.

from RTT - Biotech https://ift.tt/33X2apf
via IFTTT

No comments:

Post a Comment